Chinese Patent Medicine as Adjuvant for Mild-to-Moderate Active Ulcerative Colitis: A Network Meta-Analysis of Randomized Controlled Trials

OBJECTIVE: To evaluate the effectiveness and safety of Chinese patent medicine for mild-to-moderate active ulcerative colitis (UC) using network meta-analysis (NMA). METHODS: We systematically searched PubMed, Cochrane library, Embase, Sino-Med, China National Knowledge Infrastructure (CNKI), Wanfan...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yu-Xin, Yang, Guo-Yan, Karamacoska, Diana, Wang, Xiao, Li, Yuan-Xi, Hou, Wen-Bin, Zheng, You-You, Liu, Jian-Ping, Liu, Zhao-Lan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413025/
https://www.ncbi.nlm.nih.gov/pubmed/34484384
http://dx.doi.org/10.1155/2021/1075886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413025/
https://www.ncbi.nlm.nih.gov/pubmed/34484384
http://dx.doi.org/10.1155/2021/1075886

Ejemplares similares